Literature DB >> 23825364

Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study.

Damiano Baldassarre1, Fabrizio Veglia, Anders Hamsten, Steve E Humphries, Rainer Rauramaa, Ulf de Faire, Andries J Smit, Philippe Giral, Sudhir Kurl, Elmo Mannarino, Enzo Grossi, Rodolfo Paoletti, Elena Tremoli.   

Abstract

OBJECTIVE: To investigate whether several different measures of carotid intima-media thickness (IMT) progression are associated with subsequent vascular events and whether such associations are independent of baseline carotid atherosclerotic profile and Framingham risk factors. APPROACH AND
RESULTS: A longitudinal cohort study (the Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population study) was performed in 7 centers in 5 European countries (Finland, France, Italy, the Netherlands, and Sweden). Three thousand four hundred eighty-two subjects (median age 64.1 years; 47.8% men) with ≥ 3 vascular risk factors were recruited and monitored for a postprogression median follow-up of 21.5 months, during which time 129 subjects experienced a first vascular event (incidence of 20.4 per 1000 person-years). The 15th month progression of mean and maximum carotid IMT of the left and right common carotids, bifurcations, internal carotid arteries, and their composite measures, as well as the fastest IMTmax progression (Fastest-IMT(max-progr)) detected in the whole carotid tree regardless of location, were used in statistical analyses. All carotid IMT measures showed significant progression during the first 15 months (P<0.001), but only the Fastest-IMT(max-progr) was significantly associated with the risk of subsequent vascular events. The Fastest-IMT(max-progr) association persisted after Bonferroni correction for multiple comparisons and after adjustments for Framingham risk factors and pharmacological treatments (all P<0.005). The use of Framingham Risk Score in place of Framingham risk factors provided almost identical results (P=0.003).
CONCLUSIONS: The Fastest-IMT(max-progr), a novel approach to assess carotid IMT progression, identifies focal increases of carotid IMT and, in contrast to other progression variables, is associated with cardiovascular risk.

Entities:  

Keywords:  cardiovascular diseases; carotid artery intima-media thickness; carotid ultrasound; progression; risk prediction

Mesh:

Year:  2013        PMID: 23825364     DOI: 10.1161/ATVBAHA.113.301844

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

1.  Select aging biomarkers based on telomere length and chronological age to build a biological age equation.

Authors:  Wei-Guang Zhang; Shu-Ying Zhu; Xiao-Juan Bai; De-Long Zhao; Shi-Min Jian; Juan Li; Zuo-Xiang Li; Bo Fu; Guang-Yan Cai; Xue-Feng Sun; Xiang-Mei Chen
Journal:  Age (Dordr)       Date:  2014-06

2.  Adiposity has no direct effect on carotid intima-media thickness in adolescents and young adults: Use of structural equation modeling to elucidate indirect & direct pathways.

Authors:  Zhiqian Gao; Philip R Khoury; Connie E McCoy; Amy S Shah; Thomas R Kimball; Lawrence M Dolan; Elaine M Urbina
Journal:  Atherosclerosis       Date:  2015-12-08       Impact factor: 5.162

3.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

4.  Residential Exposure to PM2.5 and Ozone and Progression of Subclinical Atherosclerosis Among Women Transitioning Through Menopause: The Study of Women's Health Across the Nation.

Authors:  Chunzhe Duan; Evelyn O Talbott; Rachel Broadwin; Maria Brooks; Karen Matthews; Emma Barinas-Mitchell
Journal:  J Womens Health (Larchmt)       Date:  2019-02-07       Impact factor: 2.681

Review 5.  Cardiometabolic Disorders in Psoriatic Disease.

Authors:  Curtis Sobchak; Lihi Eder
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

6.  C/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD).

Authors:  Marco Fernandes; Alisha Patel; Holger Husi
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

7.  Intima modifier locus 2 controls endothelial cell activation and vascular permeability.

Authors:  Elaine M Smolock; Ryan M Burke; Chenjing Wang; Tamlyn Thomas; Sri N Batchu; Xing Qiu; Martha Zettel; Keigi Fujiwara; Bradford C Berk; Vyacheslav A Korshunov
Journal:  Physiol Genomics       Date:  2014-07-01       Impact factor: 3.107

8.  Multivariate Brain Activity while Viewing and Reappraising Affective Scenes Does Not Predict the Multiyear Progression of Preclinical Atherosclerosis in Otherwise Healthy Midlife Adults.

Authors:  Peter J Gianaros; Javier Rasero; Caitlin M DuPont; Thomas E Kraynak; James J Gross; Kateri McRae; Aidan G C Wright; Timothy D Verstynen; Emma Barinas-Mitchell
Journal:  Affect Sci       Date:  2022-02-19

9.  Prevalence and Predictors of Abdominal Aorta Calcification in Patients With Psoriasis-A Case Control Study.

Authors:  Sofia Ramos; Sheetal Daya; Nigel J Crowther; Lushen Pillay; Mohammed Tikly; Nasrin Goolam Mahyoodeen
Journal:  Front Med (Lausanne)       Date:  2022-06-30

10.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.

Authors:  Ljubica Perisic Matic; Urszula Rykaczewska; Anton Razuvaev; Maria Sabater-Lleal; Mariette Lengquist; Clint L Miller; Ida Ericsson; Samuel Röhl; Malin Kronqvist; Silvia Aldi; Joelle Magné; Valentina Paloschi; Mattias Vesterlund; Yuhuang Li; Hong Jin; Maria Gonzalez Diez; Joy Roy; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Ulf de Faire; Elena Tremoli; Jacob Odeberg; Vladana Vukojević; Janne Lehtiö; Lars Maegdefessel; Ewa Ehrenborg; Gabrielle Paulsson-Berne; Göran K Hansson; Jan H N Lindeman; Per Eriksson; Thomas Quertermous; Anders Hamsten; Ulf Hedin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.